321805
Disparities in risk of preterm birth and low birth weight for immigrant women in South Korea
This study compared birth data of immigrant and native women in ROK and explored factors affecting birth outcomes of immigrant women.
We examined 72,080 singletons from immigrant women and 1,695,686 singletons from natives based on the National Birth Registration Database between 2010 and 2013. The outcomes included preterm births (PTB) and low birth weight (LBW). We calculated adjusted proportions for the occurrence of PTB and LBW and performed stratified analysis by maternal age, parity, and birth region. We also assessed the associated factors with those birth outcomes in multivariate analyses adjusted for maternal and paternal factors.
The adjusted proportions of PTB (4.79% vs. 4.47%, p<0.001) and LBW (4.10% vs. 3.57%, p<0.001) were significantly higher for immigrants than natives. The results of stratified analysis show that primiparous immigrant women residing in non-capital area and those between the ages of 20-34 had statistically significantly higher proportions of PTB or LBW relative to native women. Multivariate analysis revealed that parental ages and residential place were related to PTB and LBW.
We found worse birth outcomes in immigrant women than those of native women. Integrated policies are needed to address such health disparities of immigrant women in Korea.
Learning Areas:
Administration, management, leadershipDiversity and culture
Public health or related public policy
Learning Objectives:
Discuss preterm birth and low birth weight infants and related factors of immigrant women in newly emerging multicultural country, Republic of Korea.
Keyword(s): Birth Outcomes, Immigrant Health
Qualified on the content I am responsible for because: I am an associate professor in Seoul National University College of Medicine.
I have been researching birth outcomes and health disparities.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.